Showing 1 - 6 of 6 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
PF-03654746 is a potent, selective antagonist of the human H3 receptor, developed by Pfizer. It was in the clinical trial phase II for the treatment of excessive daytime sleepiness (EDS) associated with narcolepsy, Tourette syndrome as well as poten...
4-Bromo-2-fluorobenzyl bromide is used for the organic synthesis. It is an intermediate useful in the preparation of angiotensin II antagonists and the retinoic acid receptor–related orphan receptors inverse agonists.
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
PF-03654746 is a potent, selective antagonist of the human H3 receptor, developed by Pfizer. It was in the clinical trial phase II for the treatment of excessive daytime sleepiness (EDS) associated with narcolepsy, Tourette syndrome as well as poten...
